Home / Specialties / Cardiology (page 6)

Cardiology

Cardiovascular Health and Diabetes: Diabetes is an inflammatory, cardiometabolic disease. It elevates nearly every cardiovascular risk factor, and most diabetes patients will die from cardiovascular disease. However, insights from new clinical research along with patient education provide new edges to improve cardiovascular outcomes in your diabetes patients.

Finerenone improves cardiovascular outcomes in patients with Type 2 Diabetes and CKD

Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, improves cardiovascular events (MI, stroke, HF) in Type 2 Diabetes and Chronic Kidney Disease (CKD) patients.  Some risk factors for cardiovascular diseases (CVD), such as high blood glucose, blood pressure, serum cholesterol, and BMI, are also associated with CKD and type 2 diabetes. …

Read More »

Sickle Cell Disease and Diabetes Mellitus

Is there a link between patients living with sickle cell disease and diabetes mellitus? African-Americans/ Black are the most affected by sickle cell disease (SCD). According to the US Department of Health and Human Services Office of Minority Health, this population also has the highest prevalence of obesity. Sickle cell …

Read More »

Influence of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus

Sodium-glucose cotransporter 2 inhibitors lower the risk of hospitalization in heart failure and cardiovascular death…  The SIMPLE trial examined the effects of empagliflozin on myocardial flow reserve, showing microvascular perfusion in individuals with type 2 diabetes with high CVD risk. The SIMPLE trial is a single-center, double-blind, randomized clinical trial …

Read More »

DPP-4 Inhibitors Vs. Sulphonylureas As Add-On to Metformin – Assessing CV Outcomes in Type 2 Diabetes

New retrospective study results compare the two most largely prescribed antidiabetic medication classes in addition to metformin, to determine the impact on the incidence of CV events in patients with T2DM. Dipeptidyl-peptidase-4 inhibitors (DPP-4i) and sulphonylureas (sulfonylureas in the US) (SU) are two of the most prescribed medication to date …

Read More »